Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported routine equity compensation activity. On February 6, 2026, 119 shares of common stock were acquired upon vesting and settlement of restricted stock units, and 48 shares were withheld at $127.42 per share to cover taxes.
After these transactions, Sarbaugh directly owns 2,110 shares of Zoetis common stock. He also holds time-based restricted stock units that each represent a contingent right to receive one share, including 120 RSUs from a February 6, 2024 grant, 1,528.0167 RSUs from a March 31, 2023 grant, and 1,159.7099 RSUs from a February 19, 2025 grant, all vesting in three equal annual installments subject to continued service.
Zoetis Inc. Chief Executive Officer and director Kristin C. Peck reported multiple equity transactions involving company stock and restricted stock units (RSUs). On February 6, 2026, RSU vesting led to the acquisition of 5,555 shares of common stock, followed by the disposition of 1,914 shares at $127.42 per share. On February 8, 2026, additional RSUs vested, generating 6,224 shares of common stock, with 2,722 shares disposed of at $127.42 per share.
After these transactions, Peck directly held 101,337 shares of Zoetis common stock and 833.6435 common stock equivalents in the Zoetis Savings Plan (401(k)) as of December 31, 2025, along with 22,062.8977 RSUs outstanding under the company’s equity incentive plan.
Zoetis Inc. declared a quarterly dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on June 2, 2026 to shareholders of record as of the close of business on April 20, 2026. The company also noted that the related information is being furnished under Regulation FD and not treated as filed for liability purposes.
Zoetis Inc. chief executive Kristin C. Peck reported an acquisition of 367.2079 phantom stock units on January 9, 2026, under the Zoetis Supplemental Savings Plan. These units are a form of deferred, cash-settled compensation whose value is tied to Zoetis common stock plus a small portion of cash-equivalent investments. After this transaction, Peck holds a total of 58,410.776 phantom stock units directly. Each unit represents a fraction of a phantom share of Zoetis common stock and typically includes around 5% of its value in cash-equivalent investments, so the total value moves with the Zoetis share price and the value of those cash-equivalent holdings.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported an acquisition of derivative-based compensation tied to the company’s stock. On 01/09/2026, he acquired 149.604 phantom stock units under the Zoetis Supplemental Savings Plan at a reference value of $42.42 per unit, bringing his holdings in this plan-related instrument to 1,247.7606 phantom stock units held directly.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, which typically account for around 5% of the unit’s total value. The units are settled in cash following his separation from service, and their value is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments.
Zoetis Inc. Executive Vice President Kevin Esch reported an award of cash-settled phantom stock units linked to Zoetis common stock. On 01/09/2026, he acquired 100.6422 phantom stock units at a reference value of $42.42 per unit, bringing his total to 277.038 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after his separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small portion of cash-equivalent investments, with the value determined by the market price of Zoetis stock and the value of those cash-equivalent holdings.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported acquiring 217.6054 phantom stock units on January 9, 2026 at a reference price of $42.42 per unit. After this transaction, he holds a total of 6,803.5995 phantom stock units in a company plan. These units were acquired under the Zoetis Supplemental Savings Plan and are designed to be settled in cash after his separation from service, rather than in actual Zoetis shares.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, which typically makes up around 5% of the unit’s total value. The value of the units is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments, so their value moves generally in line with the stock over time.
Zoetis Inc. Executive Vice President Rimma Driscoll reported an acquisition of 141.4427 phantom stock units on January 9, 2026. These units were credited at a reference value of $42.42 per unit under the Zoetis Supplemental Savings Plan, bringing her total phantom stock unit balance to 5,367.8047 units held as a direct interest. The phantom stock units are settled in cash after her separation from service, and their value is determined by the market value of Zoetis common stock plus a small portion in cash-equivalent investments, which typically represent around 5% of each unit’s total value.
Zoetis Inc. Executive Vice President Roxanne Lagano reported acquiring 190.4046 phantom stock units on January 9, 2026, at a transaction price of $42.42 per unit. Following this transaction, she beneficially owns 28,815.1316 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s total value. The value of these units is determined by the market value of Zoetis common stock and the associated cash-equivalent investments.
Zoetis Inc. executive Julie Fuller reported a new grant of 190.4045 phantom stock units on January 9, 2026. The filing shows the units were acquired at a reference value of $42.42 per unit, bringing her total phantom stock unit balance to 578.0564 held directly.
These phantom stock units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, with the cash-equivalent investments typically around 5% of the unit’s total value. The value of the award therefore tracks the market value of Zoetis common stock together with the related cash-equivalent investments.